IMMX
Immix Biopharma·NASDAQ
--
--(--)
--
--(--)
IMMX fundamentals
Immix Biopharma (IMMX) released its earnings on Aug 8, 2025: revenue was -- (YoY --), beat estimates; EPS was -0.22 (YoY -46.67%), missed estimates.
Revenue / YoY
--
--
EPS / YoY
-0.22
-46.67%
Report date
Aug 8, 2025
EPS
Actual | -0.23 | -0.23 | -0.15 | -0.24 | -0.18 | -0.15 | -0.22 | |
Forecast | -0.23 | -0.23 | -0.23 | -0.15 | -0.16 | -0.25 | -0.23 | -0.16 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | -50.00% | +28.00% | +34.78% | -37.50% |
Revenue
Actual | 0 | -- | -- | -- | -- | -- | -- | -- |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | -- | -- |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What does Immix Biopharma do and what are its main business segments?Did Immix Biopharma beat or miss consensus estimates last quarter?What is Immix Biopharma's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Immix Biopharma year over year?What factors drove the changes in Immix Biopharma's revenue and profit?What is the market's earnings forecast for Immix Biopharma next quarter?What is Immix Biopharma's gross profit margin?What guidance did Immix Biopharma's management provide for the next earnings period?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
